ProKidney Corp.
PROK · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | – | $175,667 | $256,466 | $491,132 |
| - Cash | $95,323 | $84,940 | $97,805 | $99,120 |
| + Debt | $3,245 | $3,515 | $3,369 | $3,236 |
| Enterprise Value | – | $94,242 | $162,030 | $395,248 |
| Revenue | $217 | $221 | $230 | $76 |
| % Growth | -1.8% | -3.9% | 202.6% | – |
| Gross Profit | -$1,181 | $221 | $230 | $76 |
| % Margin | -544.2% | 100% | 100% | 100% |
| EBITDA | -$33,883 | -$34,651 | -$35,761 | -$45,205 |
| % Margin | -15,614.3% | -15,679.2% | -15,548.3% | -59,480.3% |
| Net Income | -$16,469 | -$16,552 | -$16,734 | -$21,278 |
| % Margin | -7,589.4% | -7,489.6% | -7,275.7% | -27,997.4% |
| EPS Diluted | -0.12 | -0.13 | -0.13 | -0.17 |
| % Growth | 7.7% | 0% | 23.5% | – |
| Operating Cash Flow | -$26,596 | -$31,416 | -$29,592 | -$24,171 |
| Capital Expenditures | -$5,197 | -$3,112 | -$1,135 | -$25,509 |
| Free Cash Flow | -$31,793 | -$34,528 | -$30,727 | -$49,680 |